Published in Obesity and Diabetes Week, July 7th, 2003
Researchers at the Keck School of Medicine of the University of Southern California presented the new findings at the American Diabetes Association's 63rd Annual Scientific Sessions on June 17, 2003, in New Orleans, Louisiana.
The Pioglitazone in Prevention of Diabetes (PIPOD) study tested whether pioglitazone could continue protecting women from diabetes just as troglitazone had done in the researchers' prior study, TRIPOD. Both drugs appear to reduce the demands placed on beta cells, which...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week